|
||||||||||||||||||||||
|
|
Basic Trial Information
Summary Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy. Further Study Information STUDY PLAN 1. Only the principal investigator, sub-investigators, and research nurse will be approaching potential participants. The above listed also will be the only consentors for the study. The recruitment process will occur during the outpatient visits being held at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. HIPAA guidelines and good clinical practice will be followed at all times to ensure that the privacy of participants included in the recruitment process are strictly guarded. 2. Patients will be registered by the Radiation Oncology clinical subjects coordinator after eligibility is confirmed and informed consent is obtained. 3. The EORTC QLQ-C30, QLQ-CR38, and QLQ-CR29 forms will be completed by patients at the following time point: 1. Within 3 weeks prior to start of radiotherapy 2. During the 4th week of radiotherapy (when treatment-related symptoms are expected to peak) 3. Approximately one month after completion of radiotherapy during a follow-up visit 4. The QOL forms (QLC-C30, QLQ-CR38, and CR29) will be self-administered surveys. A nurse or other healthcare provider will be available to help the patient with any questions regarding the QOL forms. 5. The symptom inventory will be collected in an interview by a nurse or other healthcare provider at the following time points: d. Within 3 weeks prior to start of radiotherapy e. Once weekly during radiotherapy f. Approximately one month after completion of radiotherapy during a follow-up visit. Eligibility Criteria Inclusion Criteria:
1. Is there a working diagnosis of rectal cancer? YES NO 2. Will the patient be receiving neoadjuvant concurrent chemotherapy and pelvic radiation? YES NO 3. Is the pelvic radiation planned for a dose of 45-54 Gy and will it be delivered using a standard 3-field technique? YES NO 4. Is the patient ≥ 18 years of age? YES NO 5. Can the patient give informed consent? YES NO Exclusion Criteria:
1. Has there been prior radiation to the pelvis? YES NO 2. Is the patient in the "special category" designated by the Public Health Service (patients younger than 18, pregnant women, and prisoners)? YES NO Trial Lead Organizations/Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University of Michigan Comprehensive Cancer Center
Trial Sites
Link to the current ClinicalTrials.gov record. Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain
the same text. Minor
changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and
contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should
be directed to ClinicalTrials.gov. Back to Top |
NCI Home |
Images Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
A Service of the National Cancer Institute |